Earnings History Data for Passage Bio (PASG) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Passage Bio
Passage Bio Inc. is a genetic medicines company. It is focused on developing transformative therapies for rare, monogenic central nervous system diseases. The company's principal product includes GM1 gangliosidosis, frontotemporal dementia and Krabbe disease which is in clinical stage. Passage Bio Inc. is based in Philadelphia, United States.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13-11-2024 | PM | PASG | Passage Bio | 40.00 | -0.31 | -0.23 | 0.00 | Passage Bio GAAP EPS of -$0.31 misses by $0.08 [11/13/2024 8:17 AM] |
0.5868 | -0.08 (-12.16%) |
0.67 | 0.0 (0.30%) |
0.54 - 1.79 | 255,351 | 150,000 | 8,686 | ||
08-08-2024 | PM | PASG | Passage Bio | 51.00 | -0.26 | -0.31 | 0.00 | Passage Bio GAAP EPS of -$0.26 [8/8/2024 8:29 AM] |
0.7871 | -0.04 (-4.36%) |
0.0 | 0.0 (0.00%) |
0.58 - 1.79 | 156,932 | 460,000 | 0 | ||
14-05-2024 | PM | PASG | Passage Bio | 91.00 | -0.30 | -0.37 | 0.00 | Passage Bio GAAP EPS of -$0.30 [5/14/2024 7:27 AM] |
1.32 | -0.16 (-10.81%) |
0.0 | 0.0 (0.00%) |
0.58 - 1.79 | 129,858 | 140,000 | 0 | ||
13-11-2023 | PM | PASG | Passage Bio | 37.00 | -0.49 | -0.47 | 0.00 | Passage Bio GAAP EPS of -$0.49 misses by $0.03 [11/13/2023 7:38 AM] |
0.60 | 0.0 (0.00%) |
0.63 | 0.03 (5.00%) |
0.58 - 1.92 | 515,597 | 390,000 | 6,936 | ||
07-08-2023 | PM | PASG | Passage Bio | 48.00 | -0.44 | -0.48 | 0.00 | Passage Bio GAAP EPS of -$0.44 beats by $0.03 [8/7/2023 7:23 AM] |
0.84 | -0.04 (-4.55%) |
0.93 | 0.05 (5.48%) |
0.80 - 2.27 | 218,171 | 160,000 | 696 | ||
11-05-2023 | PM | PASG | Passage Bio | 57.00 | -0.63 | -0.49 | 0.00 | Passage Bio GAAP EPS of -$0.63 misses by $0.13 [5/11/2023 10:01 AM] |
1.01 | 0.0 (0.00%) |
1.00 | -0.01 (-0.99%) |
0.95 - 2.88 | 144,827 | 90,000 | 111 | ||
06-03-2023 | PM | 7:00 AM ET (Mar 6) |
PASG | Passage Bio, Inc. | 67.10 | -0.50 | -0.48 | -0.93 | Passage Bio GAAP EPS of -$0.50 beats by $0.02 [3/6/2023 7:05 AM] |
1.23 | 0.0 (0.00%) |
1.25 | 0.02 (1.63%) |
1.04 - 3.56 | 278,156 | 180,000 | 806 | |
10-11-2022 | PM | 7:00 AM ET (Nov 10) |
PASG | Passage Bio, Inc. | 64.27 | -0.49 | -0.75 | -0.77 | Passage Bio GAAP EPS of -$0.49 beats by $0.31 [11/10/2022 7:07 AM] |
1.35 | 0.15 (12.50%) |
1.20 | 0.0 (0.00%) |
1.11 - 8.91 | 381,147 | 170,000 | 158 | |
04-08-2022 | PM | 7:00 AM ET (Aug 4) |
PASG | Passage Bio, Inc. | 120.02 | -0.73 | -0.77 | -0.90 | Passage Bio GAAP EPS of -$0.73 beats by $0.09 [8/4/2022 7:52 AM] |
2.14 | 0.03 (1.42%) |
2.11 | 0.0 (0.00%) |
1.57 - 13.07 | 233,425 | 210,000 | 3,634 | |
16-05-2022 | PM | 7:00 AM ET (May 16) |
PASG | Passage Bio, Inc. | 94.50 | -0.79 | -0.88 | -0.76 | Passage Bio GAAP EPS of -$0.79 beats by $0.09 [5/16/2022 7:03 AM] |
1.69 | -0.14 (-7.65%) |
1.83 | 0.0 (0.00%) |
1.57 - 16.25 | 382,622 | 780,000 | 4,009 | |
03-03-2022 | PM | 7:00 AM ET (Mar 3) |
PASG | Passage Bio, Inc. | 179.33 | -0.93 | -0.84 | -0.85 | Passage Bio GAAP EPS of -$0.95 misses by $0.06 [3/3/2022 7:14 AM] |
3.36 | -0.09 (-2.61%) |
3.45 | 0.0 (0.00%) |
3.18 - 22.12 | 54,673 | 320,000 | 1,272 | |
04-11-2021 | PM | 7:00 AM ET (Nov 4) |
PASG | Passage Bio, Inc. | 507.40 | -0.77 | -0.80 | -0.63 | Passage Bio EPS misses by $0.03 [11/4/2021 7:24 AM] |
8.94 | 0.22 (2.52%) |
8.94 | 0.0 (0.00%) |
8.38 - 30.87 | 722,415 | 400,000 | 3,545 | |
05-08-2021 | PM | 7:00 AM ET (Aug 5) |
PASG | Passage Bio, Inc. | 643.41 | -0.90 | -0.73 | -0.60 | Passage Bio EPS misses by $0.16 [8/5/2021 7:03 AM] |
12.63 | 0.68 (5.69%) |
11.95 | 0.0 (0.00%) |
11.56 - 30.87 | 217,714 | 280,000 | 1,286 | |
|
||||||||||||||||||
05-05-2021 | PM | 7:00 AM ET (May 5) |
PASG | Passage Bio, Inc. | 1,010 | -0.76 | -0.66 | 1.00 | Passage Bio EPS misses by $0.04 [5/5/2021 7:05 AM] |
17.33 | -0.82 (-4.52%) |
17.33 | 0.0 (0.00%) |
12.10 - 38.23 | 248,111 | 220,000 | 1,602 | |
03-03-2021 | PM | 7:00 AM ET (Mar 3) |
PASG | Passage Bio, Inc. | 1,030 | -0.85 | -0.69 | 0.00 | Passage Bio EPS misses by $0.14 [3/3/2021 7:02 AM] |
20.07 | 0.48 (2.45%) |
19.59 | 0.0 (0.00%) |
8.09 - 38.23 | 304,399 | 315,677 | 100 | |
10-11-2020 | PM | 7:00 AM ET (Nov 10) |
PASG | Passage Bio, Inc. | 769.18 | -0.63 | -0.73 | 0.00 | Passage Bio EPS beats by $0.13 [11/10/2020 7:05 AM] |
16.92 | 0.10 (0.59%) |
16.82 | 0.0 (0.00%) |
8.09 - 38.23 | 142,519 | 134,688 | 650 | |
|
||||||||||||||||||
13-08-2020 | PM | 7:00 AM ET (Aug 13) |
PASG | Passage Bio, Inc. | 722.44 | -0.60 | -0.60 | 0.00 | Passage Bio EPS misses by $0.03 [8/13/2020 7:08 AM] |
14.90 | 0.13 (0.88%) |
0.0 | 0.0 (0.00%) |
8.09 - 38.23 | 43,323 | 181,982 | 0 | |
|